To determine whether 5HT1A antagonism was effective as a general tool to prevent proliferation of lymphoma cells, we treated the rapamycin resistant DLBCL cell line Val18 with increasing concentrations of WAY and total number of cells were counted until 72 h in culture. Here, HTR1A is linked to diffuse large B-cell lymphoma.